The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies.

Description of the business

Please click on the link below for a description of the Company’s business.

Country of incorporation and main countries of operation

4D pharma plc is incorporated and headquartered in England and Wales (Company registration number: 08840579). The Company and its subsidiaries operate in the United Kingdom, the Republic of Ireland and Spain.

Directors’ details

Please click on the link below for the names and brief biographical details of of the directors, together with a description of their responsibilities.

Board Committees

Please click on the link below for information on the Audit and Risk Committee and the Remuneration Committee, together with the membership of those Committees.

Corporate Governance Code

Please click on the link below to access details of the Company’s current corporate governance arrangements.

Number of securities in issue, securities not in public hands, significant shareholders

Please click on the link below for details of the number of securities in issue, the number of securities held as treasury shares and, insofar as the Company is aware, the percentage of securities that is not in public hands together with the identity and percentage holdings of significant shareholders.

Details of any other exchanges or trading platforms

The Company has not applied or agreed to have any of its securities (including its ordinary shares) admitted or traded on any other exchanges or trading platforms.

Details of any restrictions on the transfer of securities

There are no restrictions on the transfer of securities.

Whether the Company is subject to the UK City Code on Takeovers and Mergers

The Company is subject to the UK City Code on Takeovers and Mergers.

Current constitutional documents

Please click on the link below for the articles of association.

Admission documents and circulars

Please click on the links below to access the Company’s most recent admission document, together with any circulars or similar publications sent to shareholders within the past twelve months.

Company announcements

Please click on the link below to access the notifications made by the Company in the past twelve months.

Financial information

Please click on the links below for access to the Company’s Annual and Interim Reports.

Advisers

Please click on the link below for information of the Company’s nominated advisor and other key advisors.

BACK TO TOP